Notice: This company has been marked as potentially delisted and may not be actively trading. Oaktree Acquisition (OAC) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesTrends OAC vs. TDOC, AUNA, SBC, AIRS, LFMD, TOI, SHLT, CCM, HIMS, and SWTXShould you be buying Oaktree Acquisition stock or one of its competitors? The main competitors of Oaktree Acquisition include Teladoc Health (TDOC), Auna (AUNA), SBC Medical Group (SBC), AirSculpt Technologies (AIRS), LifeMD (LFMD), Oncology Institute (TOI), SHL Telemedicine (SHLT), Concord Medical Services (CCM), Hims & Hers Health (HIMS), and SpringWorks Therapeutics (SWTX). Oaktree Acquisition vs. Teladoc Health Auna SBC Medical Group AirSculpt Technologies LifeMD Oncology Institute SHL Telemedicine Concord Medical Services Hims & Hers Health SpringWorks Therapeutics Oaktree Acquisition (NYSE:OAC) and Teladoc Health (NYSE:TDOC) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, community ranking, media sentiment, valuation, institutional ownership, analyst recommendations, risk and dividends. Which has higher earnings and valuation, OAC or TDOC? Oaktree Acquisition has higher earnings, but lower revenue than Teladoc Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOaktree AcquisitionN/AN/A$1.15MN/AN/ATeladoc Health$2.57B0.60-$220.37M-$5.88-1.50 Do analysts rate OAC or TDOC? Teladoc Health has a consensus target price of $11.26, indicating a potential upside of 27.30%. Given Teladoc Health's stronger consensus rating and higher possible upside, analysts clearly believe Teladoc Health is more favorable than Oaktree Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Oaktree Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Teladoc Health 0 Sell rating(s) 11 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.39 Do insiders and institutionals have more ownership in OAC or TDOC? 47.6% of Oaktree Acquisition shares are held by institutional investors. Comparatively, 76.8% of Teladoc Health shares are held by institutional investors. 1.0% of Teladoc Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the media favor OAC or TDOC? In the previous week, Teladoc Health had 21 more articles in the media than Oaktree Acquisition. MarketBeat recorded 21 mentions for Teladoc Health and 0 mentions for Oaktree Acquisition. Teladoc Health's average media sentiment score of 0.62 beat Oaktree Acquisition's score of 0.00 indicating that Teladoc Health is being referred to more favorably in the news media. Company Overall Sentiment Oaktree Acquisition Neutral Teladoc Health Positive Which has more risk & volatility, OAC or TDOC? Oaktree Acquisition has a beta of 0.17, suggesting that its share price is 83% less volatile than the S&P 500. Comparatively, Teladoc Health has a beta of 1.27, suggesting that its share price is 27% more volatile than the S&P 500. Is OAC or TDOC more profitable? Oaktree Acquisition has a net margin of 0.00% compared to Teladoc Health's net margin of -37.91%. Oaktree Acquisition's return on equity of 0.00% beat Teladoc Health's return on equity.Company Net Margins Return on Equity Return on Assets Oaktree AcquisitionN/A N/A N/A Teladoc Health -37.91%-10.06%-4.86% Does the MarketBeat Community favor OAC or TDOC? Teladoc Health received 680 more outperform votes than Oaktree Acquisition when rated by MarketBeat users. However, 100.00% of users gave Oaktree Acquisition an outperform vote while only 62.95% of users gave Teladoc Health an outperform vote. CompanyUnderperformOutperformOaktree AcquisitionOutperform Votes3100.00% Underperform VotesNo VotesTeladoc HealthOutperform Votes68362.95% Underperform Votes40237.05% SummaryTeladoc Health beats Oaktree Acquisition on 10 of the 15 factors compared between the two stocks. Remove Ads Get Oaktree Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for OAC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OAC vs. The Competition Export to ExcelMetricOaktree AcquisitionOffices & Clinics Of Medical Doctors IndustryMedical SectorNYSE ExchangeMarket Cap$873.17M$1.16B$5.62B$19.10BDividend YieldN/AN/A4.89%3.78%P/E RatioN/A15.2423.7732.75Price / SalesN/A1.16380.8226.88Price / Cash377.4536.0138.0517.55Price / Book173.559.106.854.50Net Income$1.15M-$52.07M$3.19B$1.02B Oaktree Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OACOaktree AcquisitionN/A$34.71+0.7%N/A+138.2%$873.17MN/A0.00N/AHigh Trading VolumeTDOCTeladoc Health3.2693 of 5 stars$9.44-1.3%$11.26+19.3%-42.3%$1.63B$2.57B-1.645,600AUNAAuna3.7597 of 5 stars$7.71-10.7%$13.53+75.5%N/A$569.54M$4.34B0.0014,958News CoverageSBCSBC Medical GroupN/A$4.60-6.1%N/AN/A$473.90M$223.34M0.00N/AHigh Trading VolumeAIRSAirSculpt Technologies1.2875 of 5 stars$4.05-10.6%$5.00+23.5%-49.8%$234.42M$188.78M-28.93240Upcoming EarningsNews CoverageLFMDLifeMD1.9777 of 5 stars$4.73-10.1%$11.14+135.6%-29.9%$204.87M$193.06M-7.39230Earnings ReportAnalyst ForecastShort Interest ↑News CoverageGap UpHigh Trading VolumeTOIOncology Institute0.6996 of 5 stars$0.72-15.0%N/A-61.8%$54.71M$378.93M-0.93660SHLTSHL Telemedicine1.7439 of 5 stars$2.43-2.8%$11.00+352.5%-61.9%$39.85M$55.94M0.00583News CoverageGap DownCCMConcord Medical Services0.5524 of 5 stars$5.07-2.3%N/A+4.7%$22.53M$471.70M0.00970Short Interest ↑News CoverageGap UpHIMSHims & Hers Health2.4936 of 5 stars$40.65-9.8%$37.23-8.4%+139.6%$9.03B$1.48B92.391,046SWTXSpringWorks Therapeutics2.8315 of 5 stars$53.28-7.8%$73.20+37.4%+5.1%$3.99B$191.59M-15.31230Short Interest ↓ Remove Ads Related Companies and Tools Related Companies Teladoc Health Competitors Auna Competitors SBC Medical Group Competitors AirSculpt Technologies Competitors LifeMD Competitors Oncology Institute Competitors SHL Telemedicine Competitors Concord Medical Services Competitors Hims & Hers Health Competitors SpringWorks Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:OAC) was last updated on 3/12/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'Trump Orders ‘National Digital Asset Stockpile’ THIS could be the coin they choose…Crypto 101 Media | SponsoredDOGE’s Next Move: Not what you thinkDonald Trump, Elon Musk and the Department of Government Efficiency have kept their word. Moving even faste...Weiss Ratings | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredYour Wealth is Under AttackHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oaktree Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oaktree Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.